ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
4
views
0
references
Top references
cited by
20
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,660
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Phase II Study of Dasatinib in Patients with Previously Treated Malignant Mesothelioma (Cancer and Leukemia Group B 30601): A Brief Report
Author(s):
Arkadiusz Dudek
,
Herbert Pang
,
Robert Kratzke
,
Gregory A. Otterson
,
Lydia Hodgson
,
Everett E. Vokes
,
Hedy L. Kindler
Publication date:
2012-04-01
Journal:
Journal of Thoracic Oncology
Publisher:
Ovid Technologies (Wolters Kluwer Health)
Read this article at
ScienceOpen
Publisher
PMC
Further versions
open (via free pdf)
oa repository (via OAI-PMH doi match)
oa repository (via pmcid lookup)
Powered by
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Point-Of-Care Testing for Hepatitis
Author and article information
Journal
DOI::
10.1097/JTO.0b013e318248242c
PMC ID::
3308128
PubMed ID::
22425926
License:
https://www.elsevier.com/tdm/userlicense/1.0/
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
2,660
Combination of dasatinib and okadaic acid induces apoptosis and cell cycle arrest by targeting protein phosphatase PP2A in chronic myeloid leukemia cells
Authors:
Buket Ozel
,
Sezgi Kipcak
,
Cigir Biray Avci
…
Effect of dasatinib on EMT-mediated-mechanism of resistance against EGFR inhibitors in lung cancer cells.
Authors:
Hiroshi Mizuuchi
,
Kenichi Suda
,
Yuichi Sesumi
…
Safety and efficacy of dasatinib in patients with advanced gastrointestinal stromal tumors refractory to imatinib and sunitinib: A single arm, multicenters, phase 2 trial.
Authors:
Jian Li
,
Ye Zhou
,
Xinhua Zhang
…
See all similar
Cited by
20
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
Authors:
Arnaud Scherpereel
,
Isabelle Opitz
,
Thierry Berghmans
…
Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma
Authors:
Yoshitaka Sekido
Biomarker-guided targeted and immunotherapies in malignant pleural mesothelioma
Authors:
Haitang Yang
,
Duo Xu
,
Ralph Schmid
…
See all cited by
Version 1
- Current
Version 1